Latest Disseminated herpes zoster Stories
Epiphany Biosciences has announced that a Phase IIb dose-ranging study to evaluate the safety, efficacy, and tolerability of the company's lead compound, valomaciclovir in patients with acute herpes zoster infection, will continue as originally designed following an interim analysis. In addition to the Phase IIb zoster study, valomaciclovir will also be studied in a separate Phase II clinical trial as a therapy in managing the most severe sequelae of a herpes-zoster infection, post-herpetic...
- Boughs or branches.
- Warbling of birds in trees.